Avience Biomedicals Ltd
Avience Biomedicals Ltd Live Price Chart
Performance
| Previous Close | ₹ 338.2 |
| High | ₹ 348 |
| Volume | 46800 |
| 52W Range | ₹ 222 - ₹ 414.95 |
| Open | ₹ 339.95 |
| Low | ₹ 333.45 |
| Market Cap | ₹ 149.47 Cr |
Avience Biomedicals Ltd Technicals
| 20 Day | ₹ 0.000 |
| 50 Day | ₹ 0.000 |
| 100 Day | ₹ 0.000 |
| 200 Day | ₹ 0.000 |
| 20 Day | ₹ 0.000 |
| 50 Day | ₹ 0.000 |
| 100 Day | ₹ 0.000 |
| 200 Day | ₹ 0.000 |
Avience Biomedicals Ltd Fundamentals
| ROCE | 21.881 |
| P/E Ratio | 27.850 |
| P/B Ratio | 2.180 |
| Industry P/E | 2.180 |
| Debt to Equity | 92.346 |
| ROE | 24.811 |
| EPS | 12.280 |
| Dividend Yield | 0.000 |
| Book Value | 157.087 |
| Face Value | 10.000 |
Avience Biomedicals Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 35.4983 | 29.5376 | 16.636008 | 10.9336 | 10.1494 |
| Total Expenses | 26.016 | 22.5974 | 13.886866 | 9.9697 | 9.1832 |
| Profit After Tax | 6.7333 | 5.0021 | 2.001199 | 0.7826 | 0.7183 |
Avience Biomedicals Ltd Shareholding Pattern
| Promoter Holdings | 64.592 % |
| FIIs | 3.063 % |
| DIIs | 8.831 % |
| MutualFund | 0.252 % |
| Retail | 13.569 % |
| Others - | 9.694 % |
About Avience Biomedicals Ltd
Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi. Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India. In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions. The Company has expanded its product range from IVD rapid test kits to include a comprehensive line of medical devices such as Serology products, Biochemistry Analyser and Biochemistry Reagents, showcasing a dedication to addressing various healthcare needs. Being purely into B2B and B2G market, products cater to Pathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide as well as overseas. In addition to manufacturing, the Company also act as distributors and traders of medical equipments. A new ...
Similar Stocks
| Apollo Hospitals Enterprise Ltd Healthcare | ₹ 8,889.00 +0.5 (+0.01%) |
| Kovai Medical Center & Hospital Ltd Healthcare | ₹ 6,090.50 -10.5 (-0.17%) |
| Vimta Labs Ltd Healthcare | ₹ 599.30 +1.8 (+0.3%) |
| One Global Service Provider Ltd Healthcare | ₹ 538.75 +7.85 (+1.48%) |
| KMC Speciality Hospitals (India) Ltd Healthcare | ₹ 156.23 -1.69 (-1.07%) |
| Dr Agarwals Eye Hospital Ltd Healthcare | ₹ 5,209.00 +50 (+0.97%) |
FAQs on Avience Biomedicals Ltd
1. Can I buy Avience Biomedicals Ltd from PL Capital? ›
2. Does Avience Biomedicals Ltd pay dividends? ›
3. What is the current share price of Avience Biomedicals Ltd ? ›
4. What is the 52-week high and low of Avience Biomedicals Ltd ? ›
5. What is the market capitalisation of Avience Biomedicals Ltd? ›
6. What is the current P/E ratio of Avience Biomedicals Ltd? ›
7. What is the current P/B ratio of Avience Biomedicals Ltd? ›
8. What is the shareholding pattern of Avience Biomedicals Ltd? ›
9. What is the 1-year return of Avience Biomedicals Ltd? ›
Start SIP in Avience Biomedicals Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
